PMID: 7544392Aug 1, 1995Paper

Mortality from benign prostatic hyperplasia: worldwide trends 1950-92

Journal of Epidemiology and Community Health
C La VecchiaF Lucchini

Abstract

To provide a systematic overview of worldwide trends in mortality from benign prostatic hyperplasia (BPH) over the past four decades. This was a descriptive analysis based on age adjusted mortality rates for BPH between 1950 and 1992 for 41 countries from five continents. Official death certifications from the World Health Organization database. In the 1950s, the highest age adjusted (on the world standard population) mortality rates for BPH in Europe were in Denmark (22.8/100,000) and Germany (18.1), followed by Scandinavian countries, the UK, and Switzerland. Italy had rates around 10/100,000, and rates were lower in eastern and southern Europe (5-8/100,000). Between 1950 and 1990, a fall of over 90%, or even 95%, was observed in most western European countries. Thus, in the early 1980s, overall mortality from BPH ranged between 0.5 and 1.5/100,000 in most western European countries. In proportional terms, similar reductions were registered in other developed countries of North America, Asia (that is, Japan or Singapore), and Oceania. A fall in rates was also observed in eastern Europe and in Latin America, particularly from the late 1970s onwards, although these reductions were generally much smaller. Thus, in the early 1990...Continue Reading

References

Jan 1, 1992·Epidemiologic Reviews·H A Guess
May 1, 1992·American Journal of Epidemiology·A S Morrison
Oct 22, 1992·The New England Journal of Medicine·G J GormleyJ S Tenover
Oct 1, 1992·International Journal of Epidemiology·E FernandezJ M Antó
Jan 1, 1989·The Prostate. Supplement·J T Isaacs, D S Coffey
Jan 1, 1989·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·P Boyle
May 1, 1980·The American Journal of Medicine·J D Wilson
Feb 1, 1994·Journal of Epidemiology and Community Health·D J HunterN A Black
May 15, 1993·BMJ : British Medical Journal·D Kirk
May 26, 1993·JAMA : the Journal of the American Medical Association·G L Lu-YaoJ E Wennberg

❮ Previous
Next ❯

Citations

Mar 12, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A QuagliaM Vercelli
Aug 26, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P N PostJ W Coebergh
May 29, 2003·The Prostate·Fabio LeviCarlo La Vecchia
Sep 27, 2008·The Prostate·Lawrence D TrueThomas N Wight
Sep 4, 2004·The American Journal of Chinese Medicine·Edward M Gong, Glenn S Gerber
Sep 1, 2005·The American Journal of Geriatric Pharmacotherapy·Youlanda T Logan, Myra T Belgeri
Jul 22, 2005·The Cochrane Database of Systematic Reviews·J NiT Wu
Dec 14, 2016·Computational and Mathematical Methods in Medicine·Ernesto P EstebanStephanie M Laureano

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
François MenegozR Schaerer
© 2021 Meta ULC. All rights reserved